CHAPLIN DAVID 4
4 · OXIGENE INC · Filed Jan 24, 2013
Insider Transaction Report
Form 4
OXIGENE INCOXGN
CHAPLIN DAVID
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-01-23+6,260→ 6,260 totalExercise: $4.36From: 2013-01-23Exp: 2019-01-23→ Common Stock (6,260 underlying)
Footnotes (2)
- [F1]Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy in connection with his appointment to the Board of Directors of the Issuer and as partial payment for Board of Directors services to be provided during the first six months of 2013.
- [F2]The Stock Options were fully vested as of the grant date.